{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:24:48Z","timestamp":1791347088318,"version":"4.3.1"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>IgG4-related disease (IgG4-RD) is a rare fibro-inflammatory condition with scarce data on its clinical spectrum and management in the pediatric population.We present a single-center observational study of six children with clinically and morphologically confirmed IgG4-RD. We analyzed the age of onset, time to diagnosis, and comprehensive clinical, imaging, laboratory, and histopathological findings at presentation and during follow-up (range: 3 months to 7 years). The 2020 revised comprehensive diagnostic criteria for IgG4-RD were used. The diagnosis was based on a biopsy of orbital tissue with detection of signs of fibrosis, obliterating phlebitis, and subsequent immunohistochemical testing for the presence of IgG4. The disease manifested itself in 4 patients with orbital pseudotumor, in 1 patient with diabetes insipidus, in 1 patient with fever, signs of high inflammatory and immunological activity. The diagnostic delay ranged from 3 to 12 months. Treatment regimens included glucocorticoids combined with cytostatic agents (n=3), cytostatic monotherapy (n=2), and initial glucocorticoid monotherapy (n=1). Three patients achieved a good clinical and radiological response without disease progression. One patient experienced multiple relapses while on topical steroid therapy, which were successfully controlled after switching to systemic cytostatic therapy. Two children achieved incomplete remission. They were advised to continue rituximab therapy. This case series underscores the diagnostic challenge and phenotypic diversity of pediatric IgG4-RD. The most common clinical manifestation in our patients was orbital involvement. Prednisone and cytostatic agents were effective for inducing and maintaining remission. Our findings contribute to the evolving understanding of this rare condition in childhood.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1832660","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:51:24Z","timestamp":1778219484000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case report: The masquerading spectrum: a pediatric case series of IgG4-related disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Olga Viktorovna","family":"Shpitonkova","sequence":"first","affiliation":[{"name":"Department of Children\u2019s Diseases, Sechenov First Moscow State Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Anatolievna","family":"Geppe","sequence":"additional","affiliation":[{"name":"Department of Children\u2019s Diseases, Sechenov First Moscow State Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera Alekseevna","family":"Podzolkova","sequence":"additional","affiliation":[{"name":"Department of Children\u2019s Diseases, Sechenov First Moscow State Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Yurievna","family":"Afonina","sequence":"additional","affiliation":[{"name":"Sechenov\u2019s Center of Maternity and Childhood, Sechenov First Moscow State Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana Vladimirovna","family":"Zubareva","sequence":"additional","affiliation":[{"name":"Sechenov\u2019s Center of Maternity and Childhood, Sechenov First Moscow State Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Nikolaevna","family":"Nikolaeva","sequence":"additional","affiliation":[{"name":"Sechenov\u2019s Center of Maternity and Childhood, Sechenov First Moscow State Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Yurievna","family":"Golovanova","sequence":"additional","affiliation":[{"name":"Department of Children\u2019s Diseases, Sechenov First Moscow State Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Kirillovna","family":"Osminina","sequence":"additional","affiliation":[{"name":"Department of Children\u2019s Diseases, Sechenov First Moscow State Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Vasilievna","family":"Frolkova","sequence":"additional","affiliation":[{"name":"Department of Children\u2019s Diseases, Sechenov First Moscow State Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alekseevna","family":"Kudryashova","sequence":"additional","affiliation":[{"name":"Department of Children\u2019s Diseases, Sechenov First Moscow State Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezhda Stepanovna","family":"Podchernyaeva","sequence":"additional","affiliation":[{"name":"Department of Children\u2019s Diseases, Sechenov First Moscow State Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.05.003","article-title":"The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity","volume":"9","author":"Takahashi","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0500-7","article-title":"IgG4-related disease: an update on pathophysiology and implications for clinical care","volume":"16","author":"Perugino","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease","volume":"79","author":"Wallace","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2020.1859710","article-title":"The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD","volume":"31","author":"Umehara","year":"2021","journal-title":"Mod Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/1744666X.2023.2274358","article-title":"Pediatric IgG4-related disease: a descriptive review","volume":"20","author":"Hara","year":"2024","journal-title":"Expert Rev Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192923","article-title":"A reference interval for serum IgG subclasses in Chinese children","volume":"13","author":"Liu","year":"2018","journal-title":"PloS One"},{"key":"B7","unstructured":"Test ID: IGGS4 \u2014 IgG subclass 4, serum, pediatric"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-016-0079-3","article-title":"IgG4-related disease: a systematic review of this unrecognized disease in pediatrics","volume":"14","author":"Karim","year":"2016","journal-title":"Pediatr Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2023.100765","article-title":"Implication of allergy and atopy in IgG4-related disease","volume":"16","author":"D'Astous-Gauthier","year":"2023","journal-title":"World Allergy Organ J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214603","article-title":"Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts","volume":"78","author":"Wallace","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ19-0569","article-title":"Diagnosis and treatment of autoimmune and IgG4-related hypophysitis: clinical guidelines of the Japan Endocrine Society","volume":"67","author":"Takagi","year":"2020","journal-title":"Endocr J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae321","article-title":"A rare disease with many faces: a multicentre registry of IgG4-related disease in children","volume":"64","author":"Kaya Akca","year":"2025","journal-title":"Rheumatology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.787422","article-title":"The role of IgG4 in autoimmunity and rheumatic diseases","volume":"12","author":"Maslinska","year":"2022","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05419-x","article-title":"Coexistence of IgG4-related disease and ANCA-associated vasculitis: case report and review of the literature","volume":"44","author":"Korkmaz","year":"2024","journal-title":"Rheumatol Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13693","article-title":"Do ANCA-associated vasculitides and IgG4-related disease really overlap or not","volume":"22","author":"Erden","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.3154-23","article-title":"IgG4-related disease: recent topics on immunological aspects of this disorder and their application in new treatment strategies","volume":"64","author":"Kawano","year":"2025","journal-title":"Intern Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/art.39132","article-title":"International Consensus Guidance Statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209368","article-title":"Efficacy of abatacept for IgG4-related disease over 8 months","volume":"75","author":"Yamamoto","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2010.n.034","article-title":"Treatment with bortezomib of a patient having hyper IgG4 disease","volume":"10","author":"Khan","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1832660\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:51:24Z","timestamp":1778219484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1832660\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":19,"alternative-id":["10.3389\/fimmu.2026.1832660"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1832660","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"article-number":"1832660"}}